Fineline Cube

Follow:
14411 Articles
CGeneTech's Cetagliptin Receives NMPA Approval for Type 2 Diabetes Treatment in China
CompanyDrug

CGeneTech’s Cetagliptin Receives NMPA Approval for Type 2 Diabetes Treatment in China

Eisai and Biogen's Leqembi Approved in Mexico for Early Alzheimer's Disease Treatment
CompanyDrug

Eisai and Biogen’s Leqembi Approved in Mexico for Early Alzheimer’s Disease Treatment

AstraZeneca Appoints Iskra Reic as EVP, International, Amid Leon Wang's Investigation in China
Company

AstraZeneca Appoints Iskra Reic as EVP, International, Amid Leon Wang’s Investigation in China

Shanghai Escugen Receives NMPA Approval for Second Phase III Trial of ESG401 in TNBC
CompanyDrug

Shanghai Escugen Receives NMPA Approval for Second Phase III Trial of ESG401 in TNBC

Johnson & Johnson Submits sBLAs to FDA for Tremfya Indications in Pediatric Psoriasis and Arthritis
CompanyDrug

Johnson & Johnson Submits sBLAs to FDA for Tremfya Indications in Pediatric Psoriasis and Arthritis

GSK plc Expands Pipeline with Rgenta Therapeutics Partnership for RNA-Targeted Splice Modulators
CompanyDeals

GSK plc Expands Pipeline with Rgenta Therapeutics Partnership for RNA-Targeted Splice Modulators

Merus N.V. Receives FDA Approval for Bizengri for NRG1+ Pancreatic and Lung Cancers
CompanyDrug

Merus N.V. Receives FDA Approval for Bizengri for NRG1+ Pancreatic and Lung Cancers

Ipsen's Bylvay Receives NMPA Clearance for Treating Itching in PFIC Patients in China
CompanyDrug

Ipsen’s Bylvay Receives NMPA Clearance for Treating Itching in PFIC Patients in China

Tasly Pharma Receives NMPA Approval for Generic Lioresal (Baclofen) Oral Solution
CompanyDrug

Tasly Pharma Receives NMPA Approval for Generic Lioresal (Baclofen) Oral Solution

Humanwell Healthcare's Recombinant Plasmid Hepatocyte Growth Factor Injection Accepted for NMPA Review
CompanyDrug

Humanwell Healthcare’s Recombinant Plasmid Hepatocyte Growth Factor Injection Accepted for NMPA Review

Haisco Pharmaceutical's HSK46575 Receives NMPA Approval for Prostate Cancer Clinical Trial
CompanyDrug

Haisco Pharmaceutical’s HSK46575 Receives NMPA Approval for Prostate Cancer Clinical Trial

Sichuan Kelun-Biotech's SKB500 Receives NMPA Clinical Clearance for Solid Tumor Treatment
CompanyDrug

Sichuan Kelun-Biotech’s SKB500 Receives NMPA Clinical Clearance for Solid Tumor Treatment